These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38698370)

  • 61. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
    Wang M; Feng Z; Li X; Sun S; Lu L
    Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extracellular vesicles from Aggregatibacter actinomycetemcomitans exhibit potential antitumorigenic effects in oral cancer: a comparative in vitro study.
    Metsäniitty M; Hasnat S; Öhman C; Salo T; Eklund KK; Oscarsson J; Salem A
    Arch Microbiol; 2024 May; 206(6):244. PubMed ID: 38702412
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
    Yang G; Yang Y; Tang H; Yang K
    Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.
    Cui Z; Sun S; Liu Q; Zhou X; Gao S; Peng P; Li Q
    Biochem Cell Biol; 2020 Apr; 98(2):154-163. PubMed ID: 31265790
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
    Sun S; Cui Z; Yan T; Wu J; Liu Z
    Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
    [TBL] [Abstract][Full Text] [Related]  

  • 66.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 67. E-cadherin, β-catenin, and α2β1 and α3β1 integrin expression in primary oral squamous cell carcinoma and its regional metastasis.
    Soares MQ; Mendonça JA; Morais MO; Leles CR; Batista AC; Mendonça EF
    Histol Histopathol; 2015 Oct; 30(10):1213-22. PubMed ID: 25857731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
    Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
    Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fusobacterium nucleatum Promotes Cisplatin-Resistance and Migration of Oral Squamous Carcinoma Cells by Up-Regulating Wnt5a-Mediated NFATc3 Expression.
    Da J; Wang X; Li L; Xu Y
    Tohoku J Exp Med; 2021 Apr; 253(4):249-259. PubMed ID: 33840648
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 71. LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway.
    Ai Y; Wu S; Zou C; Wei H
    J Cell Mol Med; 2020 Sep; 24(18):10512-10524. PubMed ID: 32691935
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma.
    Chang C; Geng F; Shi X; Li Y; Zhang X; Zhao X; Pan Y
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1393-1404. PubMed ID: 30470868
    [TBL] [Abstract][Full Text] [Related]  

  • 73. p12CDK2-AP1 interacts with CD82 to regulate the proliferation and survival of human oral squamous cell carcinoma cells.
    Chai J; Ju J; Zhang SW; Shen ZY; Liang L; Yang XM; Ma C; Ni QW; Sun MY
    Oncol Rep; 2016 Aug; 36(2):737-44. PubMed ID: 27349208
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma.
    Cai L; Zhu H; Mou Q; Wong PY; Lan L; Ng CWK; Lei P; Cheung MK; Wang D; Wong EWY; Lau EHL; Yeung ZWC; Lai R; Meehan K; Fung S; Chan KCA; Lui VWY; Cheng ASL; Yu J; Chan PKS; Chan JYK; Chen Z
    NPJ Biofilms Microbiomes; 2024 Apr; 10(1):39. PubMed ID: 38589501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Implications of Differential Expression of β-Catenin in Oral Carcinoma.
    Moles MA; Montoya JA; Salvago MD; Ávila IR; Campillo JJ; Bravo M
    Anticancer Res; 2016 Apr; 36(4):1599-604. PubMed ID: 27069136
    [TBL] [Abstract][Full Text] [Related]  

  • 76. p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signaling.
    Li L; Ji S; Shrestha C; Jiang Y; Liao L; Xu F; Liu Z; Bikle DD; Xie Z
    J Cell Physiol; 2020 Dec; 235(12):9399-9413. PubMed ID: 32356317
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma.
    Liu Z; Tao H
    J Cell Biochem; 2020 Mar; 121(3):2150-2158. PubMed ID: 31762107
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complex.
    Li YY; Zhou CX; Gao Y
    Oral Oncol; 2015 Oct; 51(10):935-43. PubMed ID: 26194050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
    Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
    Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1.
    Jin S; Ma H; Yang W; Ju H; Wang L; Zhang Z
    J Mol Med (Berl); 2018 Jun; 96(6):513-525. PubMed ID: 29713760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.